Thomas Fuchs
Director · GeneDx Holdings Corp.
Individual
- 2025
- Sep 18, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Thomas Fuchs files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Keith A. Meister - $74.03M in WGS purchases and sales in the last 12 months
- Casdin Capital, LLC - $32.57M in WGS purchases and sales in the last 12 months
- Katherine Stueland - $9.37M in WGS purchases and sales in the last 12 months
- Joshua Ruch - $6.09M in WGS purchases and sales in the last 12 months
- Kevin Feeley - $2.60M in WGS purchases and sales in the last 12 months
- Bryan Dechairo - $851K in WGS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Thomas Fuchs?
Thomas Fuchs is a corporate insider, tracked as Director of GeneDx Holdings Corp. (WGS). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Thomas Fuchs submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
